QRxPharma Limited (QRX:ASX) Investor Relations Material

Overview

QRxPharma Limited is a pharmaceutical company that specializes in producing and marketing pain management and central nervous system disorder therapies. The company is in the clinical stage of development and is focused on bringing solutions to market that address these conditions. QRxPharma's goal is to provide effective treatment options for patients that improve their quality of life. As a specialty pharmaceutical company, QRxPharma has the expertise necessary to create highly targeted therapies that soothe and heal pain and brain-related conditions. The company is a valuable player in the healthcare industry because it offers solutions to pressing medical needs that affect millions of people worldwide.

Frequently Asked Questions

What is QRxPharma Limited's ticker?

QRxPharma Limited's ticker is QRX

What exchange is QRxPharma Limited traded on?

The company's shares trade on the ASX stock exchange

Where are QRxPharma Limited's headquarters?

They are based in Sydney, New South Wales

How many employees does QRxPharma Limited have?

There are 1-10 employees working at QRxPharma Limited

What is QRxPharma Limited's website?

It is http://www.qrxpharma.com/

What type of sector is QRxPharma Limited?

QRxPharma Limited is in the Healthcare sector

What type of industry is QRxPharma Limited?

QRxPharma Limited is in the Medical Laboratories & Research industry

Who are QRxPharma Limited's peers and competitors?

The following five companies are QRxPharma Limited's industry peers:

- Quest Diagnostics

- Natera

- Organovo Holdings Inc

- Fluidigm Corporation

- T2 Biosystems